The civic-run King Edward Memorial (KEM) Hospital in Mumbai at present started part II and III trials of the Oxford Covishield vaccine for COVID-19, an official stated.
The hospital, situated in Parel space, on Tuesday obtained the approval of the Maharashtra ethics committee for conducting the vaccine trials.
King Edward Memorial Hospital Dean Dr Hemant Deshmukh instructed information company Press Belief of India that the hospital has began screening volunteers for the trials.
The medical facility will probably be conducting the trials on 100 volunteers, he stated.
The Mumbai-based BYL Nair Hospital, one other facility run by the Brihanmumbai Municipal Company, has additionally obtained approval for conducting trials of the vaccine.
Each the King Edward Memorial Hospital and BYL Nair Hospital will probably be conducting the trials collectively on over 200 volunteers, sources instructed information company PTI.
As a part of the trials, volunteers who’re discovered damaging for coronavirus in each RT-PCR and antigen checks will probably be given the vaccine, they stated.
Trials of the Oxford vaccine candidate are being performed in Pune as nicely.
The Pune-based Serum Institute of India (SII) has partnered with British-Swedish pharma firm AstraZeneca for manufacturing the COVID-19 vaccine candidate, being developed by the College of Oxford, UK.
(Apart from the headline, this story has not been edited by NDTV employees and is revealed from a syndicated feed.)